This website uses cookies

This website uses cookies to improve user experience. By using our website you consent to all cookies in accordance with our Cookie Policy.

Essential cookies enable basic functions and are necessary for the website to function properly.
Statistics cookies collect information anonymously. This information helps us to understand how our visitors use our website.
Marketing cookies are used by third parties or publishers to display personalized advertisements. They do this by tracking visitors across websites.

PASSION FOR PRECISION

Delivering the promise of radiopharmaceuticals 
to patients.

Our Mission

We aim to provide the most precise cancer radiodiagnostics and therapeutics to fight hard-to-treat tumors. We are leveraging our
radioisotope leadership to build a broad precision oncology pipeline to improve clinical outcomes and quality of life for patients living with cancer.

Latest News

See all →

ITM to Provide COMPETE Trial Insights at SNMMI 2025 Annual Meeting in Oral Presentation and Satellite Symposium

Garching / Munich, Germany, June 13, 2025 -ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, today announced…

Read more

ITM Secures Up to $262.5m in Non-dilutive Debt Financing with Blue Owl Managed Funds

  • Debt capital to support commercial readiness and potential U.S. launch of n.c.a.177Lu-edotreotide (ITM-11), following positive Phase 3 results
  • Flexible…

Read more

ITM and Radiopharm Sign Supply Agreement for n.c.a. Lutetium-177

Garching / Munich, Germany and Sydney, Australia, May 19, 2025 – ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech…

Read more

ITM has one of the deepest, broadest clinical RPT pipelines

Global supply of targeted diagnostic and therapeutic radiopharmaceuticals

Delivering the Promise of Radiopharmaceuticals to Patients

Precision Diagnostics and Therapeutics

Your Career at ITM - Precisely for You